Md. Code Regs. 10.09.69.17 – Table of Rare and Expensive Disease Diagnosis.

ICD10	ICD 10 Description	Age Limit
B20	Human immunodeficiency virus (HIV) disease	0—20
C96.0	Multifocal and multisystemic Langerhans-cell histiocytosis	0—64
C96.5	Multifocal and unisystemic Langerhans-cell histiocytosis	0—64
C96.6	Unifocal Langerhans-cell histiocytosis	0—64
D61.01	Constitutional (pure) red blood cell aplasia	0—20
D61.09	Other constitutional aplastic anemia	0—20
D66	Hereditary factor VIII deficiency	0—64
D67	Hereditary factor IX deficiency	0—64
D68.00	Von Willebrand disease, unspecified	0—64
D68.01	Von Willebrand disease, type 1	0—64
D68.020	Von Willebrand disease, type 2A	0—64
D68.021	Von Willebrand disease, type 2B	0—64
D68.022	Von Willebrand disease, type 2M	0—64
D68.023	Von Willebrand disease, type 2N	0—64
D68.029	Von Willebrand disease, type 2, unspecified	0—64
D68.03	Von Willebrand disease, type 3	0—64
D68.04	Acquired von Willebrand disease	0—64
D68.09	Other von Willebrand disease	0—64
D68.1	Hereditary factor XI deficiency	0—64
D68.2	Hereditary deficiency of other clotting factors	0—64
E70.0	Classical phenylketonuria	0—20
E70.1	Other hyperphenylalaninemias	0—20
E70.20	Disorder of tyrosine metabolism, unspecified	0—20
E70.21	Tyrosinemia	0—20
E70.29	Other disorders of tyrosine metabolism	0—20
E70.30	Albinism, unspecified	0—20
E70.40	Disorders of histidine metabolism, unspecified	0—20
E70.41	Histidinemia	0—20
E70.49	Other disorders of histidine metabolism	0—20
E70.5	Disorders of tryptophan metabolism	0—20
E70.81	Aromatic L-amino acid decarboxylase deficiency	0—20
E70.89	Other disorders of amino-acid metabolism	0—20
E71.110	Isovaleric acidemia	0—20
E71.111	3-methylglutaconic aciduria	0—20
E71.118	Other branched-chain organic acidurias	0—20
E71.120	Methylmalonic acidemia	0—20
E71.121	Propionic acidemia	0—20
E71.128	Other disorders of propionate metabolism	0—20
E71.19	Other disorders of branched-chain amino-acid metabolism	0—20
E71.2	Disorder of branched-chain amino-acid metabolism, unspecified	0—20
E71.310	Long chain/very long chain acyl CoA dehydrogenase deficiency	0—64
E71.311	Medium chain acyl CoA dehydrogenase deficiency	0—64
E71.312	Short chain acyl CoA dehydrogenase deficiency	0—64
E71.313	Glutaric aciduria type II	0—64
E71.314	Muscle carnitine palmitoyltransferase deficiency	0—64
E71.318	Other disorders of fatty-acid oxidation	0—64
E71.32	Disorders of ketone metabolism	0—64
E71.39	Other disorders of fatty-acid metabolism	0—64
E71.41	Primary carnitine deficiency	0—64
E71.42	Carnitine deficiency due to inborn errors of metabolism	0—64
E71.50	Peroxisomal disorder, unspecified	0—64
E71.510	Zellweger syndrome	0—64
E71.511	Neonatal adrenoleukodystrophy	0—64
E71.518	Other disorders of peroxisome biogenesis	0—64
E71.520	Childhood cerebral X-linked adrenoleukodystrophy	0—64
E71.521	Adolescent X-linked adrenoleukodystrophy	0—64
E71.522	Adrenomyeloneuropathy	0—64
E71.528	Other X-linked adrenoleukodystrophy	0—64
E71.529	X-linked adrenoleukodystrophy, unspecified type	0—64
E71.53	Other group 2 peroxisomal disorders	0—64
E71.540	Rhizomelic chondrodysplasia punctata	0—64
E71.541	Zellweger-like syndrome	0—64
E71.542	Other group 3 peroxisomal disorders	0—64
E71.548	Other peroxisomal disorders	0—64
E72.01	Cystinuria	0—20
E72.02	Hartnup’s disease	0—20
E72.03	Lowe’s syndrome	0—20
E72.04	Cystinosis	0—20
E72.09	Other disorders of amino-acid transport	0—20
E72.11	Homocystinuria	0—20
E72.12	Methylenetetrahydrofolate reductase deficiency	0—20
E72.19	Other disorders of sulfur-bearing amino-acid metabolism	0—20
E72.20	Disorder of urea cycle metabolism, unspecified	0—20
E72.21	Argininemia	0—20
E72.22	Arginosuccinic aciduria	0—20
E72.23	Citrullinemia	0—20
E72.29	Other disorders of urea cycle metabolism	0—20
E72.3	Disorders of lysine and hydroxylysine metabolism	0—20
E72.4	Disorders of ornithine metabolism	0—20
E72.51	Non-ketotic hyperglycinemia	0—20
E72.52	Trimethylaminuria	0—20
E72.53	Primary hyperoxaluria	0—20
E72.59	Other disorders of glycine metabolism	0—20
E72.81	Disorders of gamma aminobutyric acid metabolism	0—20
E72.89	Other specified disorders of amino-acid metabolism	0—20
E74.00	Glycogen storage disease, unspecified	0—20
E74.01	von Gierke disease	0—20
E74.02	Pompe disease	0—20
E74.03	Cori disease	0—20
E74.04	McArdle disease	0—20
E74.09	Other glycogen storage disease	0—20
E74.12	Hereditary fructose intolerance	0—20
E74.19	Other disorders of fructose metabolism	0—20
E74.21	Galactosemia	0—20
E74.29	Other disorders of galactose metabolism	0—20
E74.4	Disorders of pyruvate metabolism and gluconeogenesis	0—20
E75.00	GM2 gangliosidosis, unspecified	0—20
E75.01	Sandhoff disease	0—20
E75.02	Tay-Sachs disease	0—20
E75.09	Other GM2 gangliosidosis	0—20
E75.10	Unspecified gangliosidosis	0—20
E75.11	Mucolipidosis IV	0—20
E75.19	Other gangliosidosis	0—20
E75.21	Fabry (-Anderson) disease	0—20
E75.22	Gaucher disease	0—20
E75.23	Krabbe disease	0—20
E75.242	Niemann-Pick disease type C	0—20
E75.243	Niemann-Pick disease type D	0—20
E75.244	Niemann-Pick disease type A/B	0—20
E75.25	Metachromatic leukodystrophy	0—20
E75.26	Sulfatase deficiency	0—20
E75.29	Other sphingolipidosis	0—20
E75.3	Sphingolipidosis, unspecified	0—20
E75.4	Neuronal ceroid lipofuscinosis	0—20
E75.5	Other lipid storage disorders	0—20
E76.01	Hurler’s syndrome	0—64
E76.02	Hurler-Scheie syndrome	0—64
E76.03	Scheie’s syndrome	0—64
E76.1	Mucopolysaccharidosis, type II	0—64
E76.210	Morquio A mucopolysaccharidoses	0—64
E76.211	Morquio B mucopolysaccharidoses	0—64
E76.219	Morquio mucopolysaccharidoses, unspecified	0—64
E76.22	Sanfilippo mucopolysaccharidoses	0—64
E76.29	Other mucopolysaccharidoses	0—64
E76.3	Mucopolysaccharidosis, unspecified	0—64
E76.8	Other disorders of glucosaminoglycan metabolism	0—64
E77.0	Defects in post-translational mod of lysosomal enzymes	0—20
E77.1	Defects in glycoprotein degradation	0—20
E77.8	Other disorders of glycoprotein metabolism	0—20
E79.1	Lesch-Nyhan syndrome	0—64
E79.2	Myoadenylate deaminase deficiency	0—64
E79.8	Other disorders of purine and pyrimidine metabolism	0—64
E79.9	Disorder of purine and pyrimidine metabolism, unspecified	0—64
E80.3	Defects of catalase and peroxidase	0—64
E84.0	Cystic fibrosis with pulmonary manifestations	0—64
E84.11	Meconium ileus in cystic fibrosis	0—64
E84.19	Cystic fibrosis with other intestinal manifestations	0—64
E84.8	Cystic fibrosis with other manifestations	0—64
E84.9	Cystic fibrosis, unspecified	0—64
E88.40	Mitochondrial metabolism disorder, unspecified	0—64
E88.41	MELAS syndrome	0—64
E88.42	MERRF syndrome	0—64
E88.49	Other mitochondrial metabolism disorders	0—64
E88.89	Other specified metabolic disorders	0—64
F84.2	Rett’s syndrome	0—20
G11.0	Congenital nonprogressive ataxia	0—20
G11.10	Early-onset cerebellar ataxia, unspecified	0—20
G11.11	Friedreich ataxia	0—20
G11.19	Other early-onset cerebellar ataxia	0—20
G11.2	Late-onset cerebellar ataxia	0—20
G11.3	Cerebellar ataxia with defective DNA repair	0—20
G11.4	Hereditary spastic paraplegia	0—20
G11.8	Other hereditary ataxias	0—20
G11.9	Hereditary ataxia, unspecified	0—20
G12.0	Infantile spinal muscular atrophy, type I (Werdnig-Hoffman)	0—20
G12.1	Other inherited spinal muscular atrophy	0—20
G12.21	Amyotrophic lateral sclerosis	0—20
G12.22	Progressive bulbar palsy	0—20
G12.29	Other motor neuron disease	0—20
G12.8	Other spinal muscular atrophies and related syndromes	0—20
G12.9	Spinal muscular atrophy, unspecified	0—20
G24.1	Genetic torsion dystonia	0—64
G24.8	Other dystonia	0—64
G25.3	Myoclonus	0—5
G25.9	Extrapyramidal and movement disorder, unspecified	0—20
G31.81	Alpers disease	0—20
G31.82	Leigh’s disease	0—20
G31.9	Degenerative disease of nervous system, unspecified	0—20
G32.81	Cerebellar ataxia in diseases classified elsewhere	0—20
G37.0	Diffuse sclerosis of central nervous system	0—64
G37.5	Concentric sclerosis (Balo) of central nervous system	0—64
G71.00	Muscular dystrophy, unspecified	0—64
G71.01	Duchenne or Becker muscular dystrophy	0—64
G71.02	Facioscapulohumeral muscular dystrophy	0—64
G71.031	Autosomal dominant limb girdle muscular dystrophy	0—64
G71.032	Autosomal recessive limb girdle muscular dystrophy due to calpain-3 dysfunction	0—64
G71.033	Limb girdle muscular dystrophy due to dysferlin dysfunction	0—64
G71.0340	Limb girdle muscular dystrophy due to sarcoglycan dysfunction, unspecified	0—64
G71.0341	Limb girdle muscular dystrophy due to alpha sarcoglycan dysfunction	0—64
G71.0342	Limb girdle muscular dystrophy due to beta sarcoglycan dysfunction	0—64
G71.0349	Limb girdle muscular dystrophy due to other sarcoglycan dysfunction	0—64
G71.035	Limb girdle muscular dystrophy due to anoctamin-5 dysfunction	0—64
G71.038	Other limb girdle muscular dystrophy	0—64
G71.039	Limb girdle muscular dystrophy, unspecified	0—64
G71.09	Other specified muscular dystrophies	0—64
G71.11	Myotonic muscular dystrophy	0—64
G71.20	Congenital myopathy, unspecified	0—64
G71.21	Nemaline myopathy	0—64
G71.220	Centronuclear myopathy	0—64
G71.228	Other centronuclear myopathy	0—64
G71.29	Other congenial myopathy	0—64
G80.0	Spastic quadriplegic cerebral palsy	0—64
G80.1	Spastic diplegic cerebral palsy	0—20
G80.3	Athetoid cerebral palsy	0—64
G82.50	Quadriplegia, unspecified	0—64
G82.51	Quadriplegia, C1-C4 complete	0—64
G82.52	Quadriplegia, C1-C4 incomplete	0—64
G82.53	Quadriplegia, C5-C7 complete	0—64
G82.54	Quadriplegia, C5-C7 incomplete	0—64
G91.0	Communicating hydrocephalus	0—20
G91.1	Obstructive hydrocephalus	0—20
I67.5	Moyamoya disease	0—64
K91.2	Postsurgical malabsorption, not elsewhere classified	0—20
N03.A	Chronic nephritic syndrome with C3 glomerulonephritis	0—20
N03.1	Chronic nephritic syndrome with focal and segmental glomerular lesions	0—20
N03.2	Chronic nephritic syndrome w diffuse membranous glomrlneph	0—20
N03.3	Chronic neph syndrome w diffuse mesangial prolif glomrlneph	0—20
N03.4	Chronic neph syndrome w diffuse endocaplry prolif glomrlneph	0—20
N03.5	Chronic nephritic syndrome w diffuse mesangiocap glomrlneph	0—20
N03.6	Chronic nephritic syndrome with dense deposit disease	0—20
N03.7	Chronic nephritic syndrome w diffuse crescentic glomrlneph	0—20
N03.8	Chronic nephritic syndrome with other morphologic changes	0—20
N03.9	Chronic nephritic syndrome with unspecified morphologic changes	0—20
N08	Glomerular disorders in diseases classified elsewhere	0—20
N18.1	Chronic kidney disease, stage 1	0—20
N18.2	Chronic kidney disease, stage 2 (mild)	0—20
N18.30	Chronic kidney disease, stage 3, unspecified	0—20
N18.31	Chronic kidney disease, stage 3a	0—20
N18.32	Chronic kidney disease, stage 3b	0—20
N18.4	Chronic kidney disease, stage 4 (severe)	0—20
N18.5	Chronic kidney disease, stage 5	0—20
N18.6	End stage renal disease	0—20
N18.9	Chronic kidney disease, unspecified	0—20
Q01.9	Encephalocele, unspecified	0—20
Q02	Microcephaly	0—20
Q03.0	Malformations of aqueduct of Sylvius	0—20
Q03.1	Atresia of foramina of Magendie and Luschka	0—20
Q03.8	Other congenital hydrocephalus	0—20
Q03.9	Congenital hydrocephalus, unspecified	0—20
Q04.3	Other reduction deformities of brain	0—20
Q04.5	Megalencephaly	0—20
Q04.6	Congenital cerebral cysts	0—20
Q04.8	Other specified congenital malformations of brain	0—20
Q05.0	Cervical spina bifida with hydrocephalus	0—64
Q05.1	Thoracic spina bifida with hydrocephalus	0—64
Q05.2	Lumbar spina bifida with hydrocephalus	0—64
Q05.3	Sacral spina bifida with hydrocephalus	0—64
Q05.4	Unspecified spina bifida with hydrocephalus	0—64
Q05.5	Cervical spina bifida without hydrocephalus	0—64
Q05.6	Thoracic spina bifida without hydrocephalus	0—64
Q05.7	Lumbar spina bifida without hydrocephalus	0—64
Q05.8	Sacral spina bifida without hydrocephalus	0—64
Q05.9	Spina bifida, unspecified	0—64
Q06.0	Amyelia	0—64
Q06.1	Hypoplasia and dysplasia of spinal cord	0—64
Q06.2	Diastematomyelia	0—64
Q06.3	Other congenital cauda equina malformations	0—64
Q06.4	Hydromyelia	0—64
Q06.8	Other specified congenital malformations of spinal cord	0—64
Q07.01	Arnold-Chiari syndrome with spina bifida	0—64
Q07.02	Arnold-Chiari syndrome with hydrocephalus	0—64
Q07.03	Arnold-Chiari syndrome with spina bifida and hydrocephalus	0—64
Q30.1	Agenesis and underdevelopment of nose, cleft or absent nose only	0—5
Q30.2	Fissured, notched and cleft nose, cleft or absent nose only	0—5
Q31.0	Web of larynx	0—20
Q31.8	Other congenital malformations of larynx, atresia or agenesis of larynx only	0—20
Q32.1	Other congenital malformations of trachea, atresia or agenesis of trachea only	0—20
Q32.4	Other congenital malformations of bronchus, atresia or agenesis of bronchus only	0—20
Q33.0	Congenital cystic lung	0—20
Q33.2	Sequestration of lung	0—20
Q33.3	Agenesis of lung	0—20
Q33.6	Congenital hypoplasia and dysplasia of lung	0—20
Q35.1	Cleft hard palate	0—20
Q35.3	Cleft soft palate	0—20
Q35.5	Cleft hard palate with cleft soft palate	0—20
Q35.9	Cleft palate, unspecified	0—20
Q37.0	Cleft hard palate with bilateral cleft lip	0—20
Q37.1	Cleft hard palate with unilateral cleft lip	0—20
Q37.2	Cleft soft palate with bilateral cleft lip	0—20
Q37.3	Cleft soft palate with unilateral cleft lip	0—20
Q37.4	Cleft hard and soft palate with bilateral cleft lip	0—20
Q37.5	Cleft hard and soft palate with unilateral cleft lip	0—20
Q37.8	Unspecified cleft palate with bilateral cleft lip	0—20
Q37.9	Unspecified cleft palate with unilateral cleft lip	0—20
Q39.0	Atresia of esophagus without fistula	0—3
Q39.1	Atresia of esophagus with tracheo-esophageal fistula	0—3
Q39.2	Congenital tracheo-esophageal fistula without atresia	0—3
Q39.3	Congenital stenosis and stricture of esophagus	0—3
Q39.4	Esophageal web	0—3
Q42.0	Congenital absence, atresia and stenosis of rectum with fistula	0—5
Q42.1	Congen absence, atresia and stenosis of rectum without fistula	0—5
Q42.2	Congenital absence, atresia and stenosis of anus with fistula	0—5
Q42.3	Congenital absence, atresia and stenosis of anus without fistula	0—5
Q42.8	Congenital absence, atresia and stenosis of other parts of large intestine	0—5
Q42.9	Congenital absence, atresia and stenosis of large intestine, part unspecified	0—5
Q43.1	Hirschsprung’s disease	0—15
Q44.2	Atresia of bile ducts	0—20
Q44.3	Congenital stenosis and stricture of bile ducts	0—20
Q44.6	Cystic disease of liver	0—20
Q45.0	Agenesis, aplasia and hypoplasia of pancreas	0—5
Q45.1	Annular pancreas	0—5
Q45.3	Other congenital malformations of pancreas and pancreatic duct	0—5
Q45.8	Other specified congenital malformations of digestive system	0—10
Q60.1	Renal agenesis, bilateral	0—20
Q60.4	Renal hypoplasia, bilateral	0—20
Q60.6	Potter’s syndrome, with bilateral renal agenesis only	0—20
Q61.02	Congenital multiple renal cysts, bilateral only	0—20
Q61.19	Other polycystic kidney, infantile type, bilateral only	0—20
Q61.2	Polycystic kidney, adult type, bilateral only	0—20
Q61.3	Polycystic kidney, unspecified, bilateral only	0—20
Q61.4	Renal dysplasia, bilateral only	0—20
Q61.5	Medullary cystic kidney, bilateral only	0—20
Q61.9	Cystic kidney disease, unspecified, bilateral only	0—20
Q64.10	Exstrophy of urinary bladder, unspecified	0—20
Q64.12	Cloacal extrophy of urinary bladder	0—20
Q64.19	Other exstrophy of urinary bladder	0—20
Q75.0	Craniosynostosis	0—20
Q75.1	Craniofacial dysostosis	0—20
Q75.2	Hypertelorism	0—20
Q75.4	Mandibulofacial dysostosis	0—20
Q75.5	Oculomandibular dysostosis	0—20
Q75.8	Other congenital malformations of skull and face bones	0—20
Q77.4	Achondroplasia	0—1
Q77.6	Chondroectodermal dysplasia	0—1
Q77.8	Other osteochondrodysplasia with defects of growth of tubular bones and spine	0—1
Q78.0	Osteogenesis imperfecta	0—20
Q78.1	Polyostotic fibrous dysplasia	0—1
Q78.2	Osteopetrosis	0—1
Q78.3	Progressive diaphyseal dysplasia	0—1
Q78.4	Enchondromatosis	0—1
Q78.6	Multiple congenital exostoses	0—1
Q78.8	Other specified osteochondrodysplasias	0—1
Q78.9	Osteochondrodysplasia, unspecified	0—1
Q79.0	Congenital diaphragmatic hernia	0—1
Q79.1	Other congenital malformations of diaphragm	0—1
Q79.2	Exomphalos	0—1
Q79.3	Gastroschisis	0—1
Q79.4	Prune belly syndrome	0—1
Q79.59	Other congenital malformations of abdominal wall	0—1
Q89.7	Multiple congenital malformations, not elsewhere classified	0—10
R75	Inconclusive laboratory evidence of HIV	0—12 months
Z21	Asymptomatic human immunodeficiency virus infection status	0—20
Z99.11	Dependence on respirator (ventilator) status	1—64
Z99.2	Dependence on renal dialysis	21—64

Authority: Health-General Article, §§2-104(b), 15-103(b)(4)(i), and 15-105, Annotated Code of Maryland

Effective date:

Regulations .01—.17 adopted as an emergency provision effective November 8, 1996 (23:25 Md. R. 1730)

Regulations .01—.17 adopted effective March 10, 1997 (24:5 Md. R. 408)

Regulations .01, .02, .05, .06, .08—.11, and .13 amended as an emergency provision effective July 1, 1997 (24:16 Md. R. 1151); emergency status expired December 31, 1997

Regulation .01 amended effective February 9, 1998 (25:3 Md. R. 144)

Regulations .01, .02, and .14 amended as an emergency provision effective July 1, 1998 (25:16 Md. R. 1261)

Regulations .01, .02, .09, .10, and .14 amended effective January 1, 1999 (25:26 Md. R. 1925)

Regulation .01O amended effective October 16, 2000 (27:20 Md. R. 1839)

Regulation .02 amended effective February 9, 1998 (25:3 Md. R. 144)

Regulation .02 repealed as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; repealed permanently effective June 25, 2001 (28:12 Md. R. 1109)

Regulation .03 amended as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; amended permanently effective June 25, 2001 (28:12 Md. R. 1109)

Regulation .04 amended as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; amended permanently effective June 25, 2001 (28:12 Md. R. 1109)

Regulation .05 amended effective February 9, 1998 (25:3 Md. R. 144)

Regulation .05 amended as an emergency provision effective December 1, 2000 (27:26 Md. R. 2355); emergency status extended at 28:7 Md. R. 685; amended permanently effective June 25, 2001 (28:12 Md. R. 1109)

Regulation .06B amended effective February 9, 1998 (25:3 Md. R. 144)

Regulation .08 amended effective February 9, 1998 (25:3 Md. R. 144)

Regulation .09B amended effective February 9, 1998 (25:3 Md. R. 144)

Regulation .10B amended effective February 9, 1998 (25:3 Md. R. 144)

Regulation .11B amended effective February 9, 1998 (25:3 Md. R. 144)

Regulation .13B amended effective February 9, 1998 (25:3 Md. R. 144)

Regulations .01—.17 repealed and new Regulations .01—.17 adopted effective February 2, 2004 (31:2 Md. R. 84)

Regulation .02B amended effective November 6, 2006 (33:22 Md. R. 1732)

Regulation .04 amended effective December 24, 2012 (39:25 Md. R. 1613)

Regulation .05B, C amended effective November 6, 2006 (33:22 Md. R. 1732)

Regulation .05C, D amended effective October 5, 2009 (36:20 Md. R. 1528)

Regulation .07G amended effective November 6, 2006 (33:22 Md. R. 1732)

Regulation .09 amended effective November 6, 2006 (33:22 Md. R. 1732)

Regulation .12B amended effective November 5, 2007 (34:22 Md. R. 1977)

Regulation .12C amended effective November 6, 2006 (33:22 Md. R. 1732)

Regulation .13B, C amended effective November 6, 2006 (33:22 Md. R. 1732)

Regulation .13C amended effective October 14, 2013 (40:20 Md. R. 1652)

Regulation .14E, F, G adopted effective October 5, 2009 (36:20 Md. R. 1528)

Regulation .14E amended effective April 4, 2011 (38:7 Md. R. 431)

Regulation .17 amended effective November 5, 2007 (34:22 Md. R. 1977); June 30, 2008 (35:13 Md. R. 1180); October 5, 2009 (36:20 Md. R. 1528); December 27, 2010 (37:26 Md. R. 1787); December 24, 2012 (39:25 Md. R. 1613)

Regulation .17 repealed and new Regulation .17 adopted effective October 26, 2015 (42:21 Md. R. 1301)

Chapter revised effective July 2, 2018 (45:13 Md. R. 665)

Regulation .02B amended effective June 24, 2024 (51:12 Md. R. 619)

Regulation .04F amended effective May 20, 2019 (46:10 Md. R. 486)

Regulation .04K, L adopted effective November 23, 2023 (50:23 Md. R. 1005)

Regulation .11A amended effective June 24, 2024 (51:12 Md. R. 619)

Regulation .12 amended effective June 24, 2024 (51:12 Md. R. 619)

Regulation .14 amended effective November 14, 2022 (49:23 Md. R. 996); November 23, 2023 (50:23 Md. R. 1005)

Regulation .14D, E amended effective May 20, 2019 (46:10 Md. R. 486); November 18, 2019 (46:23 Md. R. 1065)

Regulation .17 amended effective May 20, 2019 (46:10 Md. R. 486); November 14, 2022 (49:23 Md. R. 996); November 23, 2023 (50:23 Md. R. 1005)